Bdh Industries [BDH] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Bdh Industries

BSE
Loading...

Aarti Drugs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bdh Industries wins in 8 metrics, Aarti Drugs wins in 12 metrics, with 0 ties. Aarti Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBdh IndustriesAarti DrugsBetter
P/E Ratio (TTM)27.4823.66Aarti Drugs
Price-to-Book Ratio4.213.26Aarti Drugs
Debt-to-Equity Ratio1.4344.92Bdh Industries
PEG Ratio1.660.37Aarti Drugs
EV/EBITDA21.9117.07Aarti Drugs
Profit Margin (TTM)13.84%7.80%Bdh Industries
Operating Margin (TTM)10.21%10.11%Bdh Industries
EBITDA Margin (TTM)10.21%10.11%Bdh Industries
Return on Equity13.49%12.28%Bdh Industries
Return on Assets (TTM)10.67%6.53%Bdh Industries
Free Cash Flow (TTM)$145.56M$674.22MAarti Drugs
Dividend Yield2.98%0.22%Bdh Industries
1-Year Return55.39%-4.79%Bdh Industries
Price-to-Sales Ratio (TTM)4.211.84Aarti Drugs
Enterprise Value$2.60B$50.47BAarti Drugs
EV/Revenue Ratio3.772.08Aarti Drugs
Gross Profit Margin (TTM)26.19%36.77%Aarti Drugs
Revenue per Share (TTM)$120$265Aarti Drugs
Earnings per Share (Diluted)$18.32$20.63Aarti Drugs
Beta (Stock Volatility)0.200.12Aarti Drugs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Bdh Industries vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Bdh Industries
Aarti Drugs
Bdh Industries Stock Overview | Aarti Drugs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bdh Industries0.69%16.29%59.55%88.44%82.43%45.46%
Aarti Drugs0.73%4.61%0.24%1.59%41.06%7.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bdh Industries55.39%244.88%560.76%583.94%2,122.81%1,684.51%
Aarti Drugs-4.79%-0.89%-50.06%219.30%2,690.01%2,872.19%

News Based Sentiment: Bdh Industries vs Aarti Drugs

Bdh Industries

News based Sentiment: MIXED

BDH Industries experienced a significant stock price increase and positive developments in promoter holding, but these gains are offset by analyst concerns about overvaluation. This creates a mixed investment narrative, making October a noteworthy but not definitively positive month for the company.

View Bdh Industries News Sentiment Analysis

Aarti Drugs

News based Sentiment: POSITIVE

Aarti Drugs reported substantial profit growth in both Q1FY26 and FY2025, coupled with increased institutional interest from Mutual Funds. While shareholding changes and recent price volatility exist, the overall narrative points towards a strengthening investment case.

View Aarti Drugs News Sentiment Analysis

Performance & Financial Health Analysis: Bdh Industries vs Aarti Drugs

MetricBDHAARTIDRUGS
Market Information
Market Cap i₹3.02B₹44.55B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i16,703201,942
90 Day Avg. Volume i17,096187,563
Last Close₹506.80₹491.60
52 Week Range₹241.00 - ₹519.80₹312.00 - ₹564.05
% from 52W High-2.50%-12.84%
All-Time High₹519.80 (Oct 03, 2025)₹1,026.95 (Oct 05, 2020)
% from All-Time High-2.50%-52.13%
Growth Metrics
Quarterly Revenue Growth0.15%0.06%
Quarterly Earnings Growth0.17%0.62%
Financial Health
Profit Margin (TTM) i0.14%0.08%
Operating Margin (TTM) i0.10%0.10%
Return on Equity (TTM) i0.13%0.12%
Debt to Equity (MRQ) i1.4344.92
Cash & Liquidity
Book Value per Share (MRQ)₹119.43₹149.84
Cash per Share (MRQ)₹54.12₹2.48
Operating Cash Flow (TTM) i₹227.86M₹2.83B
Levered Free Cash Flow (TTM) i₹92.73M₹1.68B
Dividends
Last 12-Month Dividend Yield i2.98%0.22%
Last 12-Month Dividend i₹9.00₹1.00

Valuation & Enterprise Metrics Analysis: Bdh Industries vs Aarti Drugs

MetricBDHAARTIDRUGS
Price Ratios
P/E Ratio (TTM) i27.4823.66
Forward P/E i69.9115.02
PEG Ratio i1.660.37
Price to Sales (TTM) i4.211.84
Price to Book (MRQ) i4.213.26
Market Capitalization
Market Capitalization i₹3.02B₹44.55B
Enterprise Value i₹2.60B₹50.47B
Enterprise Value Metrics
Enterprise to Revenue i3.772.08
Enterprise to EBITDA i21.9117.07
Risk & Other Metrics
Beta i0.200.12
Book Value per Share (MRQ) i₹119.43₹149.84

Financial Statements Comparison: Bdh Industries vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BDHAARTIDRUGS
Revenue/Sales i₹186.24M₹5.91B
Cost of Goods Sold i₹137.46M₹3.73B
Gross Profit i₹48.79M₹2.17B
Research & Development iN/AN/A
Operating Income (EBIT) i₹19.01M₹593.60M
EBITDA i₹26.63M₹743.90M
Pre-Tax Income i₹24.41M₹511.10M
Income Tax i₹6.14M₹-28.60M
Net Income (Profit) i₹18.27M₹539.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BDHAARTIDRUGS
Cash & Equivalents i₹307.12M₹45.77M
Total Current Assets i₹667.49M₹13.38B
Total Current Liabilities i₹169.17M₹8.37B
Long-Term Debt iN/A₹2.86B
Total Shareholders Equity i₹687.62M₹13.69B
Retained Earnings i₹457.59M₹12.40B
Property, Plant & Equipment i₹146.88M₹27.03M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BDHAARTIDRUGS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBDHAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i16,703201,942
Average Daily Volume (90 Day) i17,096187,563
Shares Outstanding i5.76M91.27M
Float Shares i2.21M39.04M
% Held by Insiders i0.57%0.60%
% Held by Institutions i0.00%0.11%

Dividend Analysis & Yield Comparison: Bdh Industries vs Aarti Drugs

MetricBDHAARTIDRUGS
Last 12-Month Dividend i₹9.00₹1.00
Last 12-Month Dividend Yield i2.98%0.22%
3-Year Avg Annual Dividend i₹5.53₹1.00
3-Year Avg Dividend Yield i1.92%0.23%
3-Year Total Dividends i₹16.60₹3.00
Ex-Dividend DateAug 01, 2025Feb 04, 2025